Behzad Farivar, MD
Behzad Farivar, MD, an associate professor, vascular and endovascular surgeon, and co-director of UVA Health’s Aortic Center, has achieved a groundbreaking milestone in the treatment of complex aortic disease. On October 17, 2024, Dr. Farivar and the UVA Aortic Team performed the first FDA-approved endovascular repair of a thoracoabdominal aortic aneurysm (TAAA) in the state of Virginia using the innovative TAMBE stent-graft. This historic achievement marks a transformative step forward in providing life-saving care for patients with these complex and high-risk conditions.
Thoracoabdominal aortic aneurysms pose significant challenges due to their complexity and the critical blood vessels they affect, which supply the kidneys, intestines, spinal cord, extremities, and other vital organs. These aneurysms have historically been associated with high morbidity and mortality rates. The Gore Excluder® Thoracoabdominal Branch Endoprosthesis (TAMBE) is the first FDA-approved stent-graft designed for the minimally invasive repair of these complex aneurysms. By eliminating the need for open surgery, this advanced device offers patients shorter recovery times, reduced hospital stays, lower complication rates, and improved long-term outcomes.
Performing the first FDA-approved TAMBE case in Virginia reflects UVA Health’s unwavering commitment to advancing aortic care through innovation and expertise. This landmark procedure required meticulous planning, cutting-edge imaging technology, and seamless collaboration among vascular surgeons, anesthesiologists, and operating room staff. Dr. Farivar’s exceptional leadership and expertise were instrumental in ensuring the operation’s success, further solidifying UVA Health’s position as a leader in aortic care in the region.
With this milestone, UVA Health’s Aortic Center continues to distinguish itself as a hub of innovation, offering hope and advanced solutions to patients across Virginia and beyond. This achievement underscores UVA Health’s dedication to delivering world-class, patient-centered care while driving forward advancements in vascular and endovascular surgery.
Filed Under: Clinical